Health Pharmaceutical Raw Materials Ostarine SARMS MK 2866 CAS 841205-47-8

Product Name	MK-2866, Ostarine
Synonyms	(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide ; GTx-024 ; Ostarine NOT FOR SALE-PATENTED ; EnobosarM ; PropanaMide, 3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoroMethyl)phenyl]-2-hydroxy-2-Methyl-, (2S)-;MK-2866 (GTx-024);(S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide MK-2866 , Ostarine;(S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropionamide
CAS	841205-47-8
MF	C19H14F3N3O3
MW	389.3
Usage	Nonsteroidal selective androgen receptor modulator (SARM) used in the treatment of osteoporosis and muscle wasting in animal models . A potential compound for the treatment of hypoactive sexual desire disorder.

Description

Ostarine (MK-2866) is a SARM developed by GTx for the prevention and treatment of muscle wasting . It may eventually be a medical prescription for the prevention of cachexia , atrophy and sarcopenia as well as for Hormone or Testosterone Replacement Therapy.

As a research chemical, Ostarine belongs to a class of chemicals know as SARMS or selective androgen receptor modulators . SARMS create selective anabolic activity at certain androgen receptors . In comparison to testosterone and other anabolic steroids , the advantage of SARMS , is they do not have androgenic activity in non-skeletal muscle tissues. Ostarine is effective in maintaining and increasing lean body mass.

Ostarine is a potent and tissue-selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis . These patent products for research purposes only use . Ostarine (GTx-024, MK-2866, Enobosarm, S-22) is an orally bioavailable nonsteroidal selective androgen receptor modulator . Therefore , ostarine can be used for treatment of conditions such as muscle wasting and osteoporosis.